Healthcare acquired infections and vaccines: the profile determines everything
29 April 2010, 6:30 am
LONDON, UK—-28th April 2010—-ExpertREACT.. Healthcare acquired infections (HAIs) continue to be a major concern to all hospital stakeholders. Beyond increased infection control and stewardship of antibiotic use, the vaccine industry is taking the possibility of further interventions seriously with major programs now in advanced clinical development. VacZine Analytics has analyzed the commercial viability of new “nosocomial vaccines” and discusses the latest issues.VISIT SITE.
Healthcare acquired infections and vaccines: the profile determines everything
LONDON, UK—-28th April 2010—-ExpertREACT.. Healthcare acquired infections (HAIs) continue to be a major concern to all hospital stakeholders. Beyond increased infection control and stewardship of antibiotic use, the vaccine industry is taking the possibility of further interventions seriously with major programs now in advanced clinical development. VacZine Analytics has analyzed the commercial viability of new “nosocomial vaccines” and discusses the latest issues.VISIT SITE.